Candel Therapeutics, Inc. · NASDAQ:CADL
Anders Hove reported a 5.20% stake in Candel Therapeutics, Inc. (Schedule 13G)
Event Jun 25, 2025 · Filed Jun 30, 2025
Anders Hove reported a 5.20% stake in Candel Therapeutics, Inc., 2,580,517 shares, as a passive investor on Jun 25, 2025. Filed Jun 30, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 2,580,517
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.20% | 1,083,818 |
| ACORN BIOVENTURES 2, L.P. | 3.00% | 1,496,699 |
| ACORN CAPITAL ADVISORS GP, LLC | 2.20% | 1,083,818 |
| Acorn Capital Advisors GP2, LLC | 3.00% | 1,496,699 |
| Anders Hove | 5.20% | 2,580,517 |